Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of roflumilast in COPD patients treated with salmeterol
2005-005080-28Phase 3Completed
- Sponsor
- Altana Pharma
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Roflumilast + salmeterol with Placebo + salmeterol (2 arms). Primary endpoint: Primary variable. Started Feb 2006; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-005080-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005080-28.